Bettina Ebert
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Genomics, phytochemicals, and oxidative stress 4
- Heme Oxygenase-1 and Carbon Monoxide 4
-
- Aldose Reductase and Taurine 8
- Co-authors
- Alfonso Lampen (4 shared papers)Edmund Maser (12 shared papers)Albrecht Seidel (2 shared papers)Michael Kisiela (8 shared papers)A. Seidel (2 shared papers)A. Lampen (1 shared paper)Adam Skarka (1 shared paper)Hans-Jörg Martin (3 shared papers)
- Journals
- Chemico-Biological Interactions (4 papers)FEBS Journal (2 papers)Drug Metabolism and Disposition (1 paper)Drug Metabolism Reviews (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- GermanyCzechiaSwitzerland
In The Last Decade
Bettina Ebert
17 papers receiving 821 citations
Peers
Comparison fields: 5 of 100
- Pharmacology 155
- Oncology 271
- Endocrinology, Diabetes and Metabolism 93
- Biological Psychiatry 13
- Health, Toxicology and Mutagenesis 73
Countries citing papers authored by Bettina Ebert
This map shows the geographic impact of Bettina Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina Ebert more than expected).
Fields of papers citing papers by Bettina Ebert
This network shows the impact of papers produced by Bettina Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina Ebert. The network helps show where Bettina Ebert may publish in the future.
Co-authors
The 18 scholars most cited alongside Bettina Ebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 192 | |
| 2 | 2011 | 116 | |
| 3 | 2006 | 105 | |
| 4 | 2007 | 66 | |
| 5 | 2008 | 62 | |
| 6 | 2004 | 51 | |
| 7 | 2011 | 48 | |
| 8 | 2010 | 42 | |
| 9 | 2014 | 35 | |
| 10 | 2005 | 31 | |
| 11 | 2014 | 24 | |
| 12 | 2011 | 21 | |
| 13 | 2017 | 12 | |
| 14 | 2011 | 12 | |
| 15 | 2016 | 10 | |
| 16 | 2018 | 10 | |
| 17 | 2012 | 10 |
About Bettina Ebert
Bettina Ebert is a scholar working on Molecular Biology, Cell Biology, Pharmacology, Health, Toxicology and Mutagenesis and Endocrinology, Diabetes and Metabolism, having authored 17 papers that have together received 847 indexed citations. Recurring topics across this work include Aldose Reductase and Taurine (8 papers), Pharmacogenetics and Drug Metabolism (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers), Hormonal Regulation and Hypertension (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Adrenal Hormones and Disorders (2 papers). The work is most often cited by research in Pharmacology (155 citations), Oncology (271 citations), Endocrinology, Diabetes and Metabolism (93 citations), Biological Psychiatry (13 citations) and Health, Toxicology and Mutagenesis (73 citations). Bettina Ebert has collaborated with scholars based in Germany, Czechia and Switzerland. Frequent co-authors include Alfonso Lampen, Edmund Maser, Albrecht Seidel, Michael Kisiela, A. Seidel, A. Lampen, Adam Skarka, Hans-Jörg Martin, Walter Meinl and Vladimı́r Wsól. Their work appears in journals such as Chemico-Biological Interactions, FEBS Journal, Drug Metabolism and Disposition, Drug Metabolism Reviews and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.